Physician profile
Shane Sopp
NPI 1497741243
$84,130.25
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61K · 2020: $17K · 2021: $6,018.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $38,765.84 | 2019-2021 | |
| Lupin INC. | $21,374.44 | 2019-2021 | |
| Therapeuticsmd, INC. | $17,216.87 | 2019-2021 | |
| Boston Scientific Corporation | $3,732.93 | 2019-2021 | |
| Axonics, INC. | $1,517.13 | 2020-2021 | |
| Pfizer INC. | $388.29 | 2019-2021 | |
| Coloplast Corp | $297.20 | 2019-2021 | |
| Astellas Pharma US INC | $237.01 | 2019-2021 | |
| Amgen INC. | $189.93 | 2019-2021 | |
| Medtronic USA, INC. | $93.56 | 2019-2020 | |
| Medtronic, INC. | $48.02 | 2021 | |
| Millicent US INC | $42.63 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $37.58 | 2019 | |
| Avion Pharmaceuticals | $30.65 | 2019-2020 | |
| Radius Health, INC. | $22.89 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $22.74 | 2019 | |
| Coopersurgical, INC. | $21.51 | 2019 | |
| Vertical Pharmaceuticals, LLC | $21.38 | 2020 | |
| Mylan Pharmaceuticals INC. | $19.64 | 2021 | |
| Rochester Medical Corporation | $17.70 | 2019 | |
| Duchesnay USA Incorporated | $16.88 | 2019 | |
| Hologic Sales and Service, LLC | $15.43 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Sopp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.